Baran Erman

Baran Erman

Auto-generated profile, based on publicly available information

Baran Erman

Can Sucak Research Laboratory for Translational Immunology, Hacettepe University, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in Blood
Verified
Journal Article
Open access
PDF file
SGSujal Ghosh
Sujal Ghosh
SBSevgi Köstel Bal
Sevgi Köstel Bal
Edwards Emily S.J.Edwards Emily S.J.
Edwards Emily S.J.
BPBethany Pillay
Bethany Pillay
RHRaúl Jiménez Heredia
Raúl Jiménez Heredia
KBKaan Boztug
Kaan Boztug
Biallelic mutations in the genes encoding CD27 or its ligand CD70 underlie inborn errors of immunity (IEIs) characterized predominantly by Epstein-Barr virus (EBV)-associated immune dysregulation, such as chronic viremia, severe infectious mononucleosis, hemophagocytic lymphohistiocytosis (HLH), lymphoproliferation, and malignancy. A comprehensive understanding of the natural history, immune characteristics, and transplant outcomes has remained elusive. Here, in a multi-institutional global collaboration, we collected the clinical information of 49 patients from 29 families (CD27, n = 33; CD70, n = 16), including 24 previously unreported individuals and identified a total of 16 distinct mutations in CD27, and 8 in CD70, respectively. The majority of patients (90%) were EBV+ at diagnosis, but only ∼30% presented with infectious mononucleosis. Lymphoproliferation and lymphoma were the main clinical manifestations (70% and 43%, respectively), and 9 of the CD27-deficient patients developed HLH. Twenty-one patients (43%) developed autoinflammatory features including uveitis, arthritis, and periodic fever. Detailed immunological characterization revealed aberrant generation of memory B and T cells, including a paucity of EBV-specific T cells, and impaired effector function of CD8+ T cells, thereby providing mechanistic insight into cellular defects underpinning the clinical features of disrupted CD27/CD70 signaling. Nineteen patients underwent allogeneic hematopoietic stem cell transplantation (HSCT) prior to adulthood predominantly because of lymphoma, with 95% survival without disease recurrence. Our data highlight the marked predisposition to lymphoma of both CD27- and CD70-deficient patients. The excellent outcome after HSCT supports the timely implementation of this treatment modality particularly in patients presenting with malignant transformation to lymphoma.

1 December 2015 in Clinical Immunology
Verified
Journal Article
Closed access
SHSevil Oskay Halaçlı
Sevil Oskay Halaçlı
DCDeniz Cagdas
Deniz Cagdas
CSCagman Sun-Tan
Cagman Sun-Tan
BEBaran Erman
Baran Erman
EYElif UZ YILDIRIM
Elif UZ YILDIRIM
OSOzden Sanal
Ozden Sanal

3 April 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
OAOzge Nur Aktaş
Ozge Nur Aktaş
AÖAyşe Bilge Öztürk
Ayşe Bilge Öztürk
BEBaran Erman
Baran Erman
SESuat Erus
Suat Erus
STSerhan Tanju
Serhan Tanju
ŞDŞükrü Dilege
Şükrü Dilege

30 April 2013 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
PDF file
SASezen Buyukozdemir Askin
Sezen Buyukozdemir Askin
EBEzel Berker
Ezel Berker
HAHakan Akincibay
Hakan Akincibay
SUSerdar Uysal
Serdar Uysal
BEBaran Erman
Baran Erman
EKErdem Karabulut
Erdem Karabulut

13 March 2015 in Haematologica
Verified
Journal Article
Open access
PDF file
BEB. Erman
B. Erman
IBI. Bilic
I. Bilic
THT. Hirschmugl
T. Hirschmugl
ESE. Salzer
E. Salzer
DCDeniz Cagdas
Deniz Cagdas
KBK. Boztug
K. Boztug
Combined immunodeficiencies (CIDs) comprise a heterogeneous group of monogenic disorders manifesting with lymphocyte defects, recurrent infections and dysregulated immune response. Recently, we and others have described clinical and molecular features of the combined immunodeficiency syndromes

14 December 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RLRomain Lévy
Romain Lévy
FGFlorian Gothe
Florian Gothe
MMMana Momenilandi
Mana Momenilandi
TMThomas Magg
Thomas Magg
MMMarie Materna
Marie Materna
VZVictorya Zakharova
Victorya Zakharova
Patients with inherited CARMIL2 or CD28 deficiency have defective T cell CD28 signaling, but their immunological and clinical phenotypes remain largely unknown. We show that only one of three CARMIL2 isoforms is produced and functional across leukocyte subsets. Tested mutant CARMIL2 alleles from 89 patients and 52 families impair canonical NF-κB but not AP-1 and NFAT activation in T cells stimulated via CD28. Like CD28-deficient patients, CARMIL2-deficient patients display recalcitrant warts and low blood counts of CD4+ and CD8+ memory T cells and CD4+ TREGs. Unlike CD28-deficient patients, they have low counts of NK cells and memory B cells, and their antibody responses are weak. CARMIL2 deficiency is fully penetrant by the age of 10 yr and is characterized by numerous infections, EBV+ smooth muscle tumors, and mucocutaneous inflammation, including inflammatory bowel disease. Patients with somatic reversions of a mutant allele in CD4+ T cells have milder phenotypes. Our study suggests that CARMIL2 governs immunological pathways beyond CD28.